
Italy aims for COVID-19 vaccine independence after 'encouraging' results from local biotech firm
The vaccine developed by Italian biotech firm ReiThera has shown 'encouraging' results in Phase I trials.
The vaccine developed by Italian biotech firm ReiThera has shown 'encouraging' results in Phase I trials.